Latest filing published 04 May 2021 for Werewolf Therapeutics, Inc., €4.2M.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -66.1%Entry US$15.91 · Close at T+365 US$5.40
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Taiho Ventures LLC: trading record in brief
Taiho Ventures LLC is a declared insider of Werewolf Therapeutics, Inc., with filings sourced from SEC (Form 4). We count 3 filings, every one of them for a trade on 4 May 2021.
Every open-market trade on record is a purchase: 1 purchase worth €4.2M, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The newest entry dates from 4 May 2021: an open-market purchase of €4.2M, in Werewolf Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Taiho Ventures LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 312,500 shares@ US$16.00100.0% of flowCommon StockSEC:0000899243-21-018120:2Canonical exit: 2 Aug 2021 (T+90)
- 438,098 sharesCommon StockSEC:0000899243-21-018120:1
- 1,318,311 sharesCommon StockSEC:0000899243-21-018120:0
3 of 3 declarations